טופמקס ספרינקל 25 מ"ג כמוסות

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

TOPIRAMATE 25 MG

Disponibbli minn:

J-C HEALTH CARE LTD

Kodiċi ATC:

N03AX11

Għamla farmaċewtika:

CAPSULES

Rotta amministrattiva:

PER OS

Manifatturat minn:

JANSSEN CILAG S.P.A., ITALY

Grupp terapewtiku:

TOPIRAMATE

Indikazzjonijiet terapewtiċi:

In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.

Data ta 'l-awtorizzazzjoni:

2012-02-01